Stroke and heart attack become curable in Mongolia

Society
bbatchimeg28@gmail.com
2018-12-24 17:18:50

Ulaanbaatar /MONTSAME/Outcomes of the 5-year project Stroke and Heart Attack, implemented with funding of USD 1.15 million from the Millennium Challenge Corporation in Mongolia and with support of the World Health Organization, has been presented on December 21 at the State Central Third Hospital (SCTH).  


Within the project, 20-bed fully equipped Acute Stroke Unit, Cardiac Intensive Care Unit and Rehabilitation Unit were set up at SCTH, for the first time at the national level, in addition to introducing advanced technologies of angiography and computed tomography and providing over 120 types of equipment for rehabilitation treatment and involving physicians and specialists in international training.


Due to stroke and heart attack, 1600 persons lost their lives in 2017 while it was 1970 persons in 2013 and the reduced number by 370 is considered as a result of the project.


The biggest outcome of the project is that Mongolian physicians succeeded to reduce number of incurable diseases in Mongolia by 4 types, creating conditions to cure themselves. About it, Director of the hospital Ts.Tumut-Ochir said that rapid progress has been made in treatment of stroke and heart attack in medical sector of Mongolia thanks to the project. Not only diagnosis and treatment, but also specialized assistance of nursing has been developed along with introduction of over 30 new technologies for diagnosis and treatment. Mongolians have more opportunity to get diagnosed and cured at home.


It is necessary to establish more units to render assistance and services in the future. Outcomes of the project has shown that it is possible to save many more lives, he emphasized. “Furthermore, we proposed the Ministry of Health to formulate program to improve care delivery framework for comprehensive medical care to the patients with stroke and acute myocardial infarction such as early detection, treatment, adequate rehabilitation and prevention of recurrence stroke and myocardial infarction.”